Alembic Pharmaceuticals has received final #USFDA approval for its generic version of Amlodipine and Atorvastatin Tablets-a comb. drug for high blood pressure and high cholesterol.
🔸Drug approved:Amlodipine + Atorvastatin   Tablets
🔸Purpose:Treats hypertension and hyperlipidemia
🔸Reference drug (RLD):Caduet by Pharmacia & Upjohn
🔸Strengths approved: 11 combinations, from 2.5/10 mg to 10/80 mg
🔸USFDA status:Therapeutically equivalent to Caduet
🔸Total USFDA approvals for Alembic:223 ANDAS
Alembic Pharmaceuticals Limited continues to expand its #US footprint with solid R&D and regulatory track record.
